Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Specimen Handling 111Magnetic Resonance Spectroscopy 111Cyclophosphamide 109pembrolizumab 78Radiotherapy 77Nivolumab 74Cisplatin 69fludarabine 68Carboplatin 61Biopsy 53Paclitaxel 46Standard of Care 45Radiosurgery 41Gemcitabine 41Dexamethasone 40Doxorubicin 38Rituximab 37venetoclax 36Radiation 36Blood Specimen Collection 36fludarabine phosphate 35Cytarabine 35Surveys and Questionnaires 34Bevacizumab 32Capecitabine 31Radiotherapy, Intensity-Modulated 30Ipilimumab 28Etoposide 28durvalumab 27Temozolomide 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cholecalciferol × 30 days × Clear all
NCT02172651 2026-05-13

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
80 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡